Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial

Background: Presumed benign ovarian tumours (PBOT) are defined by the International Ovarian Tumour Analysis (IOTA) group, without suspected sonographic criteria of cancer, without ascites or metastasis. The aim is to evaluate the efficacy of human epididymis protein 4 (HE4), cancer antigen 125 (CA12...

Descripción completa

Detalles Bibliográficos
Autores principales: Dochez, Vincent, Randet, Mélanie, Renaudeau, Céline, Dimet, Jérôme, Le Thuaut, Aurélie, Winer, Norbert, Thubert, Thibault, Vaucel, Edouard, Caillon, Hélène, Ducarme, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912210/
https://www.ncbi.nlm.nih.gov/pubmed/31699959
http://dx.doi.org/10.3390/jcm8111784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912210/
https://www.ncbi.nlm.nih.gov/pubmed/31699959
http://dx.doi.org/10.3390/jcm8111784

Ejemplares similares